Resistance to amphotericin B: emerging clinical and microbiological patterns

Drug Resistance Updates

Volumn 1, Issue 3, 1998, Pages 161-165

  Sterling, Timothy R ^a   Merz, William G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000612152     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80034-4     Document Type: Review

References (41)

1. Dick J.D., Merz W.G., and Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother 18 (1980) 158-163
2. Safe L.M., Safe S.H., Subden R.E., and Morris D.C. Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis. Can J Microbiol 23 (1977) 398-401
3. Drutz D.J., and Lehrer R.I. Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function. Am J Med Sci 276 (1978) 77-92
4. Merz W.G. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 20 (1984) 1194-1195
5. Guinet R., Chanas J., Goullier A., Bonnefoy G., and Broise-Thomas P. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol 18 (1983) 443-444
6. Bodenhoff J. Resistance studies of Candida albicans, with special reference to two patients subjected to prolonged antimycotic treatment. Odontologisk Tidskrift 76 (1968) 279-294
7. Powderly W.G., Kobayashi G.S., Herzig G.P., and Medoff G. Amphotericin B-resistant yeast infection in severely immunocompromised patients. Am J Med 84 (1988) 826-832
8. Pappagianis D., Collins M.S., Hector R., and Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 16 (1979) 123-126
9. Nguyen M.H., Peacock Jr. J.E., Morris A.J., et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 100 (1996) 617-623
10. Rex J.H., Cooper C.R., Merz W.G., et al. Detection of amphotericin B-resistant Candida isolates in a broth-based system. Antimicrob Agents Chemother 39 (1995) 906-909
11. Sterling T.R., Gasser Jr. R.A., and Ziegler A. Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host. Clin Infect Dis 23 (1996) 187-188
12. Kruger W., Sobottka I., Stockschlader M., et al. Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the MIC values. Scand J Infect Dis 28 (1996) 313-316
13. Merz W.G., and Sandford G.R. Isolation and characterization of polyene-resistant variant of Candida tropicalis. J Clin Microbiol 9 (1979) 677-680
14. Dick J.D., Rosengard B.R., Merz W.G., et al. Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii. Ann Intern Med 102 (1985) 67-68
15. Conly J., Rennie R., Johnson J., et al. Candidiasis due to amphotericin B-resistant Candida albicans. J Infect Dis 165 (1992) 761-764
16. Sweeney J.F., Greene J.N., Hiemenz J.W., et al. Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay. J Infect 33 (1996) 221-226
17. Nolte F.S., Parkinson T., Falconer D.J., et al. Isolation and characterization of fluconazole-and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 41 (1997) 196-199
18. Landman D., Saurina G., and Quale J.M. Failure of all antifungal therapy for infection due to Candida albicans: a new AIDS-related problem?. Clin Infect Dis 26 (1998) 183-184
19. Le T.P., Tuazon C.U., Levine M., et al. Resistance to fluconazole and amphotericin B in a patient with AIDS who was being treated for candidal esophagitis. Clin Infect Dis 23 (1996) 649-650
20. Kelly S.L., Lamb D.C., Kelly D.E., et al. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients [letter]. Lancet 348 (1996) 1523-1524
21. Kelly S.L., Lamb D.C., Kelly D.E., et al. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta 5,6-desaturation. FEBS Lett 400 (1997) 80-82
22. Fan-Havard P., Capano D., Smith S.M., et al. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 35 (1991) 2302-2305
23. Walsh T.J., Melcher G.P., Rinaldi M.G., et al. Trchosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 28 (1990) 1616-1622
24. Kelly S.L., Lamb D.C., Taylor M., et al. Resistance to amphotericin B associated with defective sterol delta 8->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol Lett 122 (1994) 39-42
25. Powderly W.G., Keath E.J., Sokol-Anderson M., et al. Amphotericin B-resistant Cryptococcus neoformans in a patient with AIDS. Infect Dis Clin Pract 1 (1992) 314-316
26. Schaffner A., and Bohler A. Amphotericin B refractory aspergillosis after itraconazole: evidence for significant antagonism. Mycoses 36 (1993) 421-424
27. Van't Wout J.W., Mattie H., and van Furth R. Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice. Antimicrob Agents Chemother 33 (1989) 147-151
28. Perfect J.R., and Durack D.T. Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis. Antimicrob Agents Chemother 28 (1985) 751-755
29. Anaissie E.J., Karyotakis N.C., Hachem R., et al. Correlation between in vitro and in vivo activity of antifungal agents against Candida species. J Infect Dis 170 (1994) 384-389
30. O'Day D.M., Ray W.A., Robinson R.D., and Head W.S. Correlation of in vitro and in vivo susceptibility of Candida albicans to amphotericin B and natamycin. Invest Ophthalmol Vis Sci 28 (1987) 596-603
31. Karyotakis N.C., and Anaissie E.J. Efficacy of escalating doses of liposomal amphotericin B (Amphotericin Bisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice. Antimicrob Agents Chemother 38 (1994) 2660-2662
32. Anaissie E.J., Hachem R., Karyotakis N.C., et al. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother 38 (1994) 2541-2544
33. Nguyen M.H., Clancy C.J., Yu V.L., et al. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J Infect Dis 177 (1998) 425-430
34. Rex J.H., Pfaller M.A., Rinaldi M.G., et al. Antifungal susceptibility testing. Clin Microbiol Rev 6 (1993) 367-381
35. Pierce A.M., Pierce Jr. H.D., Unrau A.M., and Oehlschlager A.C. Lipid composition and polyene antibiotic resistance of Candida albicans mutants. Can J Biochem 56 (1978) 135-142
36. Geber A., Hitchcock C.A., Swartz J.E., et al. Deletion of Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother 39 (1995) 2708-2717
37. Barchiese F., Hollis R.J., DelPoeta M., et al. Transmission of fluconazole-resistant Candida albicans between patients with AIDS and oropharyngeal candidiasis documented by pulsed-field electrophoresis. Clin Infect Dis 21 (1995) 561-564
38. (Abstract). King D., Frogatt J.W., Smith D., Angelopulos C.M., and Romagnoli M. Molecular epidemiology of an amphotericin B-, 5-FC-resistant strain of Candida lusitaniae. Abstracts of ASM 93rd General Meeting (1993) 17-17
39. Calvert H.M., Yeaman M.R., and Filler S.G. Reversible fluconazole resistance in Candida albicans. a potential in vitro model. Antimicrob Agents Chemother 41 (1997) 535-539
40. Woods R.A., Bard M., Jackson I.E., and Drutz D.J. Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria. J Infect Dis 129 (1974) 53-58
41. Maenza J.R., and Merz W.G. Candidemia: epidemiology and laboratory detection. Inf Dis Clin Pract 6 (1997) 83-88